TESORX
Live / Applied — Third extension granted (statement of use) (as of 21 Jan 2026)
What this means for you
Not registered yet, but its 15 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98134196
- Mark type
- Design + words
- Filed
- 15 Aug 2023
- Published for opposition
- 04 Jun 2024
- Attorney of record
- Kristin S. Cornuelle
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hypogonadism in men with low testosterone
Owner
- Tesorx Pharma, LLC, Menlo Park, CA, US
- Tesorx Pharma, LLC, Menlo Park, CA, US
Prosecution history
- 21 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2026 — SOU EXTENSION 3 GRANTED
- 21 Jan 2026 — SOU EXTENSION 3 FILED
- 21 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2025 — SOU EXTENSION 2 GRANTED
- 15 Jul 2025 — SOU EXTENSION 2 FILED
- 15 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jan 2025 — SOU EXTENSION 1 GRANTED
- 23 Jan 2025 — SOU EXTENSION 1 FILED
- 23 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jun 2024 — PUBLISHED FOR OPPOSITION